Immune Responses Against Myelin Basic Protein and/or Galactocerebroside Cross-React with Viruses: Implications for Demyelinating Disease

  • R. S. Fujinami
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 145)


It has long been speculated that viruses share cross-reacting determinants with their host self-components. Not until recently could this be directly demonstrated by using monoclonal antibodies (Mabs) and by making direct protein sequence comparisons. This concept of shared common determinants has been the basis for understanding the mechanisms of virus-induced autoimmunity.


Myelin Basic Protein Measle Virus Demyelinating Disease Experimental Allergic Encephalomyelitis Molecular Mimicry 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aarli J A (1974) Nervous complications of measles: cinical manifestations and prognosis. Eur Neurol 12: 79–93PubMedCrossRefGoogle Scholar
  2. Alvord EC, Jr (1984) Species-restricted encephalitogenic determinants. In: Alvord EC, Kies MW, Suckling AJ (eds) Experimental allergic encephalomyelitis. Liss, New York pp 523–537Google Scholar
  3. Applebaum E, Dolgopol VB, Dolgin J (1949) Measles encephalitis. Am J Dis Child 77: 24–48Google Scholar
  4. Applebaum E, Greenberg M and Nelson J (1953) Neurological complications following antirabiesvaccination. J Am Med Assoc 151: 188–191Google Scholar
  5. Blatt NH and Lepper MH (1953) Reactions following antirabies prophylaxis. Report on 16 patients.Am J Dis Child 86: 395–402Google Scholar
  6. Brosnan CF, Stoner GL, Bloom BR, Wisniewski HM (1977) Studies on demyelination by activated lymphocytes in the rabbit eye II. Antibody-dependent cell mediatedemyelination. J Immunol 118: 2103–2110PubMedGoogle Scholar
  7. Brosnan CF, Traugott U, Raine CS (1983) Analysis of humoral and cellular events and the role oflipid during CNS demyelination. Acta Neuropathol (Berl) [Suppl] 9: 59–70CrossRefGoogle Scholar
  8. Dales S, Fujinami RS, Oldstone MBA (1983) Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin. J Immunol 131: 1332PubMedGoogle Scholar
  9. Friedman J, Buskirk D, Marino LJ, Zabriskie JB (1987) The detection of brain antigens within the circulating immune complexes of patients with multiple sclerosis. J Neuroimmunol 14: 1–17PubMedCrossRefGoogle Scholar
  10. Fujinami RS, Oldstone MBA (1986) Amino acid homology and cross-reacting immune responses between the encephalitogenic site of myelin basic protein and virus: virus-induced autoimmunity. In: Brown F, Chancok RM, Lerner RA (eds) Vaccines 86: modern approaches to immunizations. Cold Spring Harbor Laboratory, New York, pp 247–251Google Scholar
  11. Fujinami RS, Oldstone MVBA (1987) Molecular mimicry as a mechanism for virus induced autoimmunity. In: Progress in Allergy, Triggering Factors in Autoimmunity, S Karger AG BaselGoogle Scholar
  12. Fujinami RS, Nelson JA, Walker L, Oldstone MBA (1988) Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol 62: 1001–1005Google Scholar
  13. Fujinami RS, Zurbriggen A, Powell HC (1988 b) Monoclonal antibody defines determinant betweenTheiler’s virus and galactocerebroside. J Neuroimmunol 20: 25–32PubMedCrossRefGoogle Scholar
  14. Goswami KKA, Morris RJ, Rastogi LS, Lange LS, Russell WC (1985) A neutralizing monoclonalantibody against a paramyxovirus reacts with a brain antigen. J Neuroimmunol 9: 99–108PubMedCrossRefGoogle Scholar
  15. Hochberg FH, Lehrich JR, Arnason GW (1977) Herpes simplex infection and experimental allergic encephalomyelitis: an experimental model system for reactivation of EAE. Neurology 27: 584–587PubMedGoogle Scholar
  16. Horack HM (1930) Allergy as a factor in the development of reactions to anti-rabic treatment.Am J Med Sci 197:672–682CrossRefGoogle Scholar
  17. Johnson RT, Griffin DE, Hirsch RL, Wolinsky JS, Roedenbeck S, Soziano IL, Vaisberg A (1984)Measles encephalomyelitis-clinical and immunologic studies. N Engl J Med 310: 137–141PubMedCrossRefGoogle Scholar
  18. Kennedy PGE, Watkins BA, LaThangue NB, Clements GB, Thomas DGT (1987) A cultured human oligodendroglioma cell line and herpes simplex virus-infected cells share antigenic determinants. J Neuro-Oncology 4: 389–396CrossRefGoogle Scholar
  19. Koprowski H, LaBelle I (1950) The presence of complement-fixing antibodies against brain tissue insera of persons who had received antirabies. Am J Hyg 51: 292–299PubMedGoogle Scholar
  20. Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monochlonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130: 443–454PubMedGoogle Scholar
  21. Lipton H, Miller S, Melvold R, Fujinami RS (1986) Theiler’s murine encephalomyelitis virus (TMEV) infection in mice as a model for multiple sclerosis. In: Notkins AL, Oldstone MBA (eds) Concepts in viral pathogenesis II Springer-Verlag, Berlin Heidelberg New YorkGoogle Scholar
  22. Massanari RM, Paterson PY, Lipton HL (1979) Potentiation of experimental allergic encephalomyelitis in hamsters with persistent encephalitis due to measles virus. J Infect Dis 139: 297–303PubMedCrossRefGoogle Scholar
  23. Matossian-Rogers A, Dos Santos A, Festenstein H (1987) Human cytotoxic T-cells against measles virus-infected and myelin basic protein-coated targets are cross-reactive. Int Arch Allergy Immunol 84: 159–164CrossRefGoogle Scholar
  24. Miller HG, Stanton JB, Gibbons JL (1956) Para-infectious encephalomyelitis and related syndromes: a critical review of the neurological complications of certain specific fevers. Q J Med 25: 427–505PubMedGoogle Scholar
  25. Mokhtarian F, Swoveland P (1987) Predisposition to EAE induction in resistant mice by prior infection with semliki forest virus. J Immunol 138: 3264–3268PubMedGoogle Scholar
  26. Paterson PY (1971) The demyelinating diseases: clinical and experimental correlates. In: (eds) Little, Brown, New York, pp 1269–1300Google Scholar
  27. Remlinger P (1928) Les paralysies du traitement anti-rabique. Ann Inst Past 42: 71–132Google Scholar
  28. Rivers TM, Schwentker FF (1935) Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J Exp Med 61: 689–702PubMedCrossRefGoogle Scholar
  29. Rivers TM, Sprunt DH, Berry GP (1933) Observations on attempts to produce acute disseminatedencephalomyelitis in monkeys. J Exp Med 58: 39–53PubMedCrossRefGoogle Scholar
  30. Schluesener HJ, Sobel RA, Linington C, Weiner HL (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 139: 4016–4021PubMedGoogle Scholar
  31. Uchimura I, Shiraki H (1957) A contribution to the classification and the pathogenesis of demyelinating encephalomyelitis, with special reference to the central nervous system lesions caused by preventive inoculation against rabies. J Neuropathol 16: 139–203CrossRefGoogle Scholar
  32. Waksman BH (1962) Auto-immunization and the lesions of auto-immunity. Med 41: 93–141Google Scholar
  33. Weigle WO (1980) Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv Immunol 30: 159–273PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • R. S. Fujinami
    • 1
  1. 1.Department of PathologyUniversity of CaliforniaSan Diego, La JollaUSA

Personalised recommendations